Last reviewed · How we verify
NCT05662787: RESTORE ATK
BOLT Lithotripsy RESTORE ATK Trial
NA trial testing Intravascular Lithotripsy in Peripheral Arterial Disease in 97 participants. Completed in 30 July 2024.
20 June 2024
Quick facts
| Lead sponsor | Bolt Medical |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 97 |
| Start date | 19 January 2023 |
| Primary completion | 20 June 2024 |
| Estimated completion | 30 July 2024 |
| Sites | 11 locations across Austria, Croatia, Germany |
Drugs / interventions tested
- Intravascular Lithotripsy
Conditions studied
- Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
- Peripheral Vascular Diseases — all drugs for Peripheral Vascular Diseases →
Sponsor
Bolt Medical — full company profile →
Who can join
18 and older, any sex, with Peripheral Arterial Disease or Peripheral Vascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The RESTORE (ATK) above the knee study is a prospective, non- randomized, multi-center study for treatment of stenotic lesions with the Bolt Intravascular Lithotripsy System.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05662787
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intravascular Lithotripsy
Trials testing the same drug.
- NCT07109479 — Safety and Effectiveness of the Single-Use Coronary Forward Intravascular Lithotripsy Catheter Combined With the Intrava · NA · not yet recruiting
- NCT06238518 — Intravascular Lithotripsy Versus Conventional Therapy for Severely Calcified Coronary Artery Lesions · NA · unknown
- NCT06089135 — Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Tria · NA · completed
- NCT05858905 — FORWARD PAD IDE Study With the Shockwave Javelin IVL Catheter · NA · completed
- NCT05535907 — BOLT Lithotripsy RESTORE BTK Trial · NA · completed
Other recruiting trials for Peripheral Arterial Disease
Currently open trials in the same condition.
- NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
- NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
- NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
- NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
- NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting
Other Bolt Medical trials
Trials by the same sponsor.
- NCT06181240 — Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE) · NA · active not recruiting
- NCT05535907 — BOLT Lithotripsy RESTORE BTK Trial · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05662787 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bolt Medical
- Last refreshed: 7 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05662787.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing